ASAS-PerSpA study finds Japanese patients with axial psoriatic arthritis have lower disease activity and better function than ...
Pfizer Inc. announced positive results from a phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS). Tofacitinib is not ...
PregaTips on MSN
What to expect from this chronic inflammatory arthritis
Living with ankylosing spondylitis (AS) brings its own set of challenges, especially when you think about starting a family. You might notice changes in your symptoms, energy levels, or even how your ...
According to DataM Intelligence, the global Disease-Modifying Therapies (DMTs) Market was valued at USD 65.32 billion in 2024 ...
These are more affordable versions of original biologic drugs that are frequently the best option to treat many chronic ...
As we mark World Ankylosing Spondylitis Day on 03rd May 2025, it’s time to shine a spotlight on a frequently misunderstood cause of chronic back pain and help raise awareness among patients and ...
Ankylosing Spondylitis Market Outlook 2025-2035: In 2024, the 7 major ankylosing spondylitis market reached a total value of USD 5.10 billion. Going forward, IMARC Group expects the 7MM to reach a ...
Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints such ...
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that inflames the lining of the intestine. It causes symptoms like diarrhea and belly pain. Some people with UC also have problems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback